Home › Funds › Samsara BioCapital, LLC › SEPN

Samsara BioCapital, LLC position in SEPN

SEPTERNA INC · Health Care

Samsara BioCapital, LLC reported holding 3,149,128 shares of SEPN (SEPTERNA INC) in its Q2 2026 13F filing — a position valued at US$105.5M, representing 8.66% of its reported portfolio and ranking #4 among its reported holdings. Samsara BioCapital, LLC has disclosed SEPN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)3.15M sh
Reported value held$105.46M
Portfolio Weight8.66%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's SEPN position evolved

Samsara BioCapital, LLC first disclosed a stake in SEPN in Q4 2024 at 2,768,520 shares (US$63.4M). The position peaked in Q2 2026 at 3,149,128 shares, worth US$105.5M. Across 7 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 3,149,128 shares valued at US$105.5M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.77M $63.40M New
Q1 2025 3.15M $18.23M Add
Q2 2025 3.15M $33.29M Hold
Q3 2025 3.15M $59.24M Hold
Q4 2025 3.15M $87.80M Hold
Q1 2026 3.15M $75.67M Hold
Q2 2026 3.15M $105.46M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SEPN and 13F data

SEPN (SEPTERNA INC) is a Health Care company. 72 other funds we track also report a position in SEPN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$234.3M), TRV GP V, LLC (US$208.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$148.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SEPN

All SEPN fund holders →

FAQ

How long has Samsara BioCapital, LLC held SEPN?

Samsara BioCapital, LLC has disclosed SEPN holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Samsara BioCapital, LLC's current position in SEPN?

As of Q2 2026, Samsara BioCapital, LLC holds 3.15M shares of SEPN (SEPTERNA INC), valued at $105.46M, representing 8.66% of its reported portfolio and ranking #4.

Has Samsara BioCapital, LLC been buying or selling SEPN?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC held unchanged its position in SEPN. The position peaked in Q2 2026 at 3.15M shares.

Which other funds hold SEPN?

Other major institutional holders of SEPN include RA CAPITAL MANAGEMENT, L.P., TRV GP V, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.